What does Nano Holdings, Inc. do?
Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In…
What is Nano Holdings, Inc.'s P/E and P/B ratio?
Nano Holdings, Inc. has a P/E ratio of -5.9 and a P/B ratio of 1.85.
What is Nano Holdings, Inc.'s debt-to-equity ratio?
Nano Holdings, Inc. has a debt-to-equity ratio of 0.36.
How much does Nano Holdings, Inc. owe compared with what it owns?
Nano Holdings, Inc. owes ¥0.40 for every ¥1 it owns (balance sheet Mar 2026), which is low.
What is Nano Holdings, Inc.'s Positivity rank?
Nano Holdings, Inc. is ranked #6,891 of 10,750 companies globally and #3,097 of 3,683 in Japan on PositoAI, with a Positivity Score of 20,454.
Does Nano Holdings, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for Nano Holdings, Inc..
Where can I read the latest news about Nano Holdings, Inc.?
Recent headlines about Nano Holdings, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Nano Holdings, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Nano Holdings, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.